
Pet Healthcare Market Report 2026
Global Outlook – By Type (Therapeutics, Diagnostics), By Animal Type (Canine, Feline, Equine, Avian, Other Animals), By Distribution Channel (Retail, E-Commerce, Hospital Pharmacies) – Market Size, Trends, Strategies, and Forecast to 2035
Pet Healthcare Market Overview
• Pet Healthcare market size has reached to $269.01 billion in 2025 • Expected to grow to $421.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Pet Ownership: A Catalyst For Growth In The Pet Healthcare Market • Market Trend: Pet Healthcare Market Embraces Technological Advancements With Digital Platform • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Pet Healthcare Market?
Pet healthcare refers to an approach in which preventive and therapeutic care is taken to keep the pet animal disease-free. It is useful for a healthy pet lifestyle. It entails a multifaceted strategy that includes a vet's assessment of the pet's general health and potential for illness or other health issues. The major types of pet healthcare are therapeutics and diagnostics. Therapeutics refers to products such as vaccines, anti-parasitic products, and feed additives. Therapeutics are used for treating already-infected pets. It is used to cure various types of animals, such as canines, felines, equines, avian pets, and others. They are sold through various distribution channels, such as retail, e-commerce, and hospital pharmacies.
What Is The Pet Healthcare Market Size and Share 2026?
The pet healthcare market size has grown strongly in recent years. It will grow from $269.01 billion in 2025 to $293.14 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising pet ownership, increasing disposable income, awareness about zoonotic diseases, expansion of veterinary infrastructure, growth of companion animal segment.What Is The Pet Healthcare Market Growth Forecast?
The pet healthcare market size is expected to see strong growth in the next few years. It will grow to $421.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration of telehealth and digital veterinary platforms, development of advanced pet therapeutics, growth in genetic and microbiome testing, rising demand for personalized pet nutrition, increased adoption of preventive care programs. Major trends in the forecast period include growing awareness of preventive pet healthcare, increase in routine health check-ups for pets, expansion of nutraceuticals and functional foods for pets, adoption of telemedicine and remote consultations, rising focus on multi-species pet health management.Global Pet Healthcare Market Segmentation
1) By Type: Therapeutics, Diagnostics 2) By Animal Type: Canine, Feline, Equine, Avian, Other Animals 3) By Distribution Channel: Retail, E-Commerce, Hospital Pharmacies Subsegments: 1) By Therapeutics: Vaccines, Anti-Infective Drugs, Anti-Inflammatory Drugs, Pain Management Medications, Parasiticides, Nutraceuticals 2) By Diagnostics: Laboratory Diagnostics, Imaging Diagnostics, Point-Of-Care Testing, Genetic Testing, Microbiome TestingWhat Is The Driver Of The Pet Healthcare Market?
The rising pet ownership is expected to propel the growth of the pet healthcare market forward. Pet ownership is the state of being the primary person or household responsible for the care, well-being, and control of a domesticated animal. It involves a long-term, legal, and ethical commitment. Increasing pet ownership is rising due to the growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and improved well-being through pet care. Pet healthcare plays a vital role in rising pet ownership by ensuring the well-being and longevity of pets through preventive care and by providing health education that helps new pet owners make informed decisions about their animals' care. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, rising pet ownership is driving the pet healthcare industry forward.Key Players In The Global Pet Healthcare Market
Major companies operating in the pet healthcare market are Nestle SA, Merck & Co Inc., Mars Inc., Indian Immunologicals Limited, Boehringer Ingelheim International GmbH, Colgate-Palmolive Company, Chewy Inc., Zoetis Inc., Petco Animal Supplies Inc., VCA Animal Hospitals Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Royal Canin, Ceva Santé Animale, Phibro Animal Health Corporation, Trupanion, Vetoquinol S.A., Norbrook Laboratories Ltd., Heska Corporation, Biogenesis Bago SA, Pumpkin Insurance Services Inc., PetFirst Healthcare LLC, Embark Veterinary Inc., Agrolabo SpA, Bayer Animal Health GmbH, Bioniche Animal Health Canada Inc., Novartis Animal Health US Inc.Global Pet Healthcare Market Trends and Insights
Major companies operating in the pet healthcare market are introducing innovative digital platforms to sustain their position in the market. Innovative digital platforms refer to online tools and mobile applications that provide pet health monitoring, telemedicine, appointment scheduling, and personalized care recommendations. For instance, in October 2023, Cargill Incorporated, a US-based company, launched a pet health-focused digital platform called Zoonivet, which is designed to provide convenient and accessible veterinary care to pets through e-consultations. The platform aims to simplify pet healthcare by connecting pet parents with qualified veterinarians remotely via video for their pet's primary healthcare needs.What Are Latest Mergers And Acquisitions In The Pet Healthcare Market?
In December 2023, Zenex Animal Health, an India-based animal health company, acquired Ayurveda for an undisclosed amount. The acquisition is expected to strengthen Zenex's portfolio of offerings by adding herbal products and improving the quality of its overall animal health product offerings. Ayurvet is an India-based pet healthcare company that specializes in providing natural and safe Ayurvedic and herbal medicines for pets.Regional Outlook
North America was the largest region in the pet healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pet healthcare market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Pet Healthcare Market?
The pet healthcare market consists of sales of pet healthcare diagnostic tools, medicines and preventive care products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Pet Healthcare Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $293.14 billion |
| Revenue Forecast In 2035 | $421.68 billion |
| Growth Rate | CAGR of 9.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Animal Type, Distribution Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Nestle SA, Merck & Co Inc., Mars Inc., Indian Immunologicals Limited, Boehringer Ingelheim International GmbH, Colgate-Palmolive Company, Chewy Inc., Zoetis Inc., Petco Animal Supplies Inc., VCA Animal Hospitals Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Royal Canin, Ceva Santé Animale, Phibro Animal Health Corporation, Trupanion, Vetoquinol S.A., Norbrook Laboratories Ltd., Heska Corporation, Biogenesis Bago SA, Pumpkin Insurance Services Inc., PetFirst Healthcare LLC, Embark Veterinary Inc., Agrolabo SpA, Bayer Animal Health GmbH, Bioniche Animal Health Canada Inc., Novartis Animal Health US Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
